Is There a Role for Biweekly Romiplostim in the Management of Chronic Immune Thrombocytopenia (ITP)? A Report of Three Cases

Table 1

Baseline demographic and clinical characteristics.

Characteristic	Case #1	Case #2	Case #3
Age of ITP diagnosis	57	63	46
Gender	Female	Female	Female
Weight	60 kg	120 kg	80 kg
ITP etiology	Primary	Primary	Primary
Number of prior ITP therapies	4	2	2
Prior therapies for ITP
Prednisone (maintenance)	10 mg	No	No
IVIg (# of doses)	16 doses	4 doses	21 doses
Rituximab	8 doses	4 doses	No
Splenectomy	Yes	No	Yes
Vincristine	Yes	No	No
Eltrombopag	Yes	No	No
Dexamethasone	Yes	No	No